Press Enter to search · ESC to close

Macro

Novo Nordisk Trial Shows Wegovy Injection Cuts Children’s BMI and Obesity Prevalence

Novo Nordisk’s clinical trial shows that its Wegovy injection reduces BMI and obesity prevalence in children. The trial results indicate the weight-loss drug is effective in a pediatric population, lowering both body mass index and the rate of obesity among young participants. The finding extends the company’s obesity franchise into younger patients.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback